Randomized trial analysis reveals non-adherence to fish oil or placebo increases psychosis transition in ultra-high-risk individuals, indicating treatment engagement influences clinical outcomes.
Association between non-adherence to fish oil or placebo as a risk factor of transition to psychosis in ultra-high-risk individuals in the NEURAPRO study.
No takes yet. Share an insight, caveat, or question.
PRERNA et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: